Zhou et al. found that overexpression of FTO was associated with resistance to chemoradiotherapy in CSCC, suggesting that patients with high expression of FTO were less likely to respond to CCRT despite being first-line treatment [22]. The gene discussed is FTO; the disease is skin squamous cell carcinoma.